Australia's Lumigenix Launches DTC Genomics Offering | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Lumigenix has launched what it said is the first personal genomics testing service provided directly to consumers in Australia.

The private California firm, which is owned by an Australian parent, has launched a saliva sample testing kit that provides information about predisposition to common diseases, traits such as caffeine metabolism and taste perception, and ancestry information based on haplogroups.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.